Evidence map›Paper›PMID 23798428›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumors.

Andrew T Thliveris, Brittany Schwefel, Linda Clipson, Lauren Plesh, Christopher D Zahm, Alyssa A Leystra, Mary Kay Washington, Ruth Sullivan, Dustin A Deming, Michael A Newton and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Polyclonal origins of human premalignant colorectal lesions.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Mutational Heterogeneity inClinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Tumorigenesis: it takes a village.Nature reviews. Cancer · 2015
    Review
  19. Review
  20. Evaluation of clonal origin of malignant mesothelioma.Journal of translational medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Andrew T ThliverisDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI 53704, USA.
Brittany Schwefel
Linda Clipson
Lauren Plesh
Christopher D Zahm
Alyssa A Leystra
Mary Kay Washington
Ruth Sullivan
Dustin A Deming
Michael A Newton
Richard B Halberg
University of Wisconsin–Madison · USGenetic Resources Center · JPStatistical Service · CYVanderbilt University · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
PHYSICIAN SCIENTIST TRAINING IN CANCER MEDICINET32CA009614 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MCNEEL, DOUGLAS G. · 1988 to 2014
$3.8M
Polyclonal Intestinal Tumors: Formation, Progression, and SignificanceR01CA123438 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI HALBERG, RICHARD BROTT · 2009 to 2013
$1.5M
CELL CYCLE, DEVELOPMENT, AND NEOPLASIAR01CA063677 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI DOVE, WILLIAM FRANKLIN · 1993 to 2012
$1.4M
IDENTIFICATION OF MODIFIER GENES AFFECTING NEOPLASIAK08CA084146 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI THLIVERIS, ANDREW T · 2000 to 2004
$559k
NCI NIH HHS K08 CA084146NCI NIH HHS K08 CA84146NCI NIH HHS P30 CA014520NCI NIH HHS P50 CA095103NCI NIH HHS R01 CA063677NCI NIH HHS R01 CA123438NCI NIH HHS T32 CA009135NCI NIH HHS T32 CA009614
6 · The paper itself

Abstract

Intestinal tumors from mice and humans can have a polyclonal origin. Statistical analyses indicate that the best explanation for this source of intratumoral heterogeneity is the presence of interactions among multiple progenitors. We sought to better understand the nature of these interactions. An initial progenitor could recruit others by facilitating the transformation of one or more neighboring cells. Alternatively, two progenitors that are independently initiated could simply cooperate to form a single tumor. These possibilities were tested by analyzing tumors from aggregation chimeras that were generated by fusing together embryos with unequal predispositions to tumor development. Strikingly, numerous polyclonal tumors were observed even when one genetic component was highly, if not completely, resistant to spontaneous tumorigenesis in the intestine. Moreover, the observed number of polyclonal tumors could be explained by the facilitated transformation of a single neighbor within 144 μm of an initial progenitor. These findings strongly support recruitment instead of cooperation. Thus, it is conceivable that these interactions are necessary for tumors to thrive, so blocking them might be a highly effective method for preventing the formation of tumors in the intestine and other tissues.

Indexed as

Cell Transformation, NeoplasticAnimalsEpithelial CellsGenes, APCHumansIntestinal NeoplasmsMiceMice, Inbred C57BLclonal interactionscolon cancermouse modelspatial statistics

Identifiers

PMID23798428
PMCPMC3710880
OpenAlexW2097214779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.